Subscribe to RSS
DOI: 10.1055/s-2007-967944
Ligand-Controlled Intramolecular Carbonylative Cyclization of 1,1-Diethynyl Acetates: New Entry to the Functionalized 4-Cyclopentene-1,3-diones
Publication History
Publication Date:
21 February 2007 (online)
Abstract
The carbonylative cyclization of 1,1-diethynyl acetates mediated by Phbox/Pd(TFA)2 afforded a functionalized 4-cyclopentene-1,3-dione as a major product. In the absence of box ligand, a methoxycarbonylated orthoester was obtained predominantly.
Key words
palladium - bisoxazoline - carbonylative cyclization - 1,1-diethynyl acetate - carbonylation
-
1a
Mehta G.Singh SR. Angew. Chem. Int. Ed. 2006, 45: 953 -
1b
Facundo VA.Sa AL.Silva SAF.Morais SM.Matos CRR.Braz-Filho R. J. Braz. Chem. Soc. 2004, 15: 140 -
1c
Ciufolini MA.Zhu S. J. Org. Chem. 1998, 63: 1668 -
1d
Smith AB.Branca SJ.Pilla NN.Guaciaro MA. J. Org. Chem. 1982, 47: 1855 -
2a For recent example, see:
Arnold LA.Naasz R.Minnaard AJ.Feringa BL. J. Org. Chem. 2002, 67: 7244 ; and references cited therein -
2b
Aoyama Y.Konoike T.Kanda A.Naya N.Nakajima M. Bioorg. Med. Chem. Lett. 2001, 11: 1695 -
2c
Nagasawa H,Utsu Y, andHori H. inventors; Jpn. Kokai Tokkyo Koho, JP2006151879. -
2d
Hori H.Nagasawa H.Ishibashi M.Uto Y.Hirata A.Saijo K.Ohkura K.Kirk KL.Uehara Y. Bioorg. Med. Chem. 2002, 10: 3257 -
3a
Handbook of Organopalladium Chemistry for Organic Synthesis
Vol. 2:
Negishi E. Wiley; New York: 2002. p.2309 - For recent reviews, see:
-
3b
Nakamura I.Yamamoto Y. Chem. Rev. 2004, 104: 2127 -
3c
Zeni G.Larock RC. Chem. Rev. 2004, 104: 2285 -
3d
Alonso F.Beletskaya IP.Yus M. Chem. Rev. 2004, 104: 3079 -
3e
Tietze LF.Ila H.Bell HP. Chem. Rev. 2004, 104: 3453 -
3f
Soderberg BCG. Coord. Chem. Rev. 2004, 248: 1085 -
3g
Vizer SA.Yerzhanov KB.Quntar AAAA.Dembitsky VM. Tetrahedron 2004, 60: 5499 -
3h
Muzart J. Tetrahedron 2005, 61: 5955 - For recent reviews of Pauson-Khand reaction, see:
-
4a
Blanco-Urgoiti J.Anorbe L.Perez-Serrano L.Dominguez G.Perez-Castells J. Chem. Soc. Rev. 2004, 33: 32 -
4b
Bonaga LV.Krafft ME. Tetrahedron 2004, 60: 9795 -
4c
Gibson SE.Lewis SE.Mainolfi N. J. Organomet. Chem. 2004, 689: 3873 -
4d
Gibson SE.Stevenazzi A. Angew. Chem. Int. Ed. 2003, 42: 1800 - For recent examples of transition-metal-catalyzed related reactions, see:
-
4e
Sherry BD.Maus L.Laforteza BN.Toste FD. J. Am. Chem. Soc. 2006, 128: 8132 -
4f
Liu Z.Wasmuth AS.Nelson SG. J. Am. Chem. Soc. 2006, 128: 10352 -
4g
Lo C.-Y.Lin C.-C.Cheng H.-M.Liu R.-S. Org. Lett. 2006, 8: 3153 -
4h
Simmons EM.Sarpong R. Org. Lett. 2006, 8: 2883 -
4i
Sun J.Conley MP.Zhang L.Kozmin SA. J. Am. Chem. Soc. 2006, 128: 9705 -
4j
Lian J.-J.Lin C.-C.Chang H.-K.Chen P.-C.Liu R.-S. J. Am. Chem. Soc. 2006, 128: 9661 -
4k
Luzung MR.Markham JP.Toste FD. J. Am. Chem. Soc. 2004, 126: 10858 -
4l
Jimenez-Nunez E.Claverie CK.Nieto-Oberhuber C.Echavarren AM. Angew. Chem. Int. Ed. 2006, 45: 5452 -
4m
Hashmi ASK. Angew. Chem. Int. Ed. 2005, 44: 6990 -
4n
Ojima I.Lee S.-Y. J. Am. Chem. Soc. 2000, 122: 2385 -
5a
Tamao K.Yamaguchi S.Shiro M. J. Am. Chem. Soc. 1994, 116: 11715 -
5b
Tamao K.Yamaguchi S. J Chem. Soc., Dalton Trans. 1998, 3693 -
5c
Wrackmeyer B.Suβ J. Z. Naturforsch., B: Chem. Sci. 2002, 57: 741 -
5d
Takahashi T.Xi Z.Obora Y.Suzuki N. J. Am. Chem. Soc. 1995, 117: 2665 -
6a
Marion N.Diez-Gonzalez S.Fremont P.Noble AR.Nolan SP. Angew. Chem. Int. Ed. 2006, 45: 3647 -
6b
Wang S.Zhang L. J. Am. Chem. Soc. 2006, 128: 8414 -
6c
Pujanauski BG.Prasad BAB.Sarpong R. J. Am. Chem. Soc. 2006, 128: 6786 -
6d
Zhang L.Wang S. J. Am. Chem. Soc. 2006, 128: 1442 -
6e
Zhao J.Hughes CO.Toste FD. J. Am. Chem. Soc. 2006, 128: 7436 -
6f
Zhang L. J. Am. Chem. Soc. 2005, 127: 16804 -
6g
Johansson MJ.Gorin DJ.Staben ST.Toste FD. J. Am. Chem. Soc. 2005, 127: 18002 -
6h
Prasad BAB.Yoshimoto FK.Sarpong R. J. Am. Chem. Soc. 2005, 127: 12468 -
6i
Miki K.Uemura S.Ohe K. Chem. Lett. 2005, 34: 1068 -
6j
Shi X.Gorin DJ.Toste FD. J. Am. Chem. Soc. 2005, 127: 5802 -
6k
Cariou K.Mainetti E.Fensterbank L.Malacria M. Tetrahedron 2004, 60: 9745 -
6l
Mamane V.Gress T.Krause H.Fürstner A. J. Am. Chem. Soc. 2004, 126: 8654 -
6m Recently, we have reported ‘A Gold(III)-Catalyzed Double Wacker-type Reaction of 1,1-Diethynyl Acetate’:
Kato K.Teraguchi R.Kusakabe T.Motodate S.Yamamura S.Mochida T.Akita H. Synlett 2007, 63 -
7a
Rautenstrauch V. J. Org. Chem. 1984, 49: 950 -
7b
Kataoka H.Watanabe K.Goto K. Tetrahedron Lett. 1990, 31: 4181 -
7c
Mahrwald R.Schick H. Angew. Chem., Int. Ed. Engl. 1991, 30: 593 -
7d
Bartels A.Mahrwald R.Müller K. Adv. Synth. Catal. 2004, 346: 483 -
7e
Vijaykumar D.Mao W.Kirschbaum KS.Katzenellenbogen JA. J. Org. Chem. 2002, 67: 4904 -
7f
Kato K.Yamamoto Y.Akita H. Tetrahedron Lett. 2002, 43: 6587 -
7g
Kato K.Nouchi H.Ishikura K.Takaishi S.Motodate S.Tanaka H.Okudaira K.Mochida T.Nishigaki R.Shigenobu K.Akita H. Tetrahedron 2006, 62: 2545 -
8a
Kato K.Nishimura A.Yamamoto Y.Akita H. Tetrahedron Lett. 2001, 42: 4203 -
8b
Takayama H.Kato K.Akita H. Eur. J. Org. Chem. 2006, 644 -
8c
Kato K.Yamamoto Y.Akita H. Tetrahedron Lett. 2002, 43: 4915 -
8d
Kato K.Tanaka M.Yamamoto Y.Akita H. Tetrahedron Lett. 2002, 43: 1511 -
8e
Kato K.Tanaka M.Yamamura S.Yamamoto Y.Akita H. Tetrahedron Lett. 2003, 44: 3089 -
8f
Kato K.Matsuba C.Kusakabe T.Takayama H.Yamamura S.Mochida T.Akita H.Peganova TA.Vologdin NV.Gusev OV. Tetrahedron 2006, 62: 9988 -
9a
Crosignani S.Desimoni G.Faita G.Righetti PP. Tetrahedron 1998, 54: 15721 -
9b
Hansen KB.Finney NS.Jacobsen EN. Angew. Chem. Int. Ed. 1995, 34: 676 -
9c
The Phbox ligands 10 and (±)-4 were prepared as easily separable mixture by the condensation of racemic phenyl glycinol with dimethylmalonyl dichloride. See:
-
9d
Lee S.Lee WM.Sulikowski GA. J. Org. Chem. 1999, 64: 4224 -
10a
Pearson RG. J. Am. Chem. Soc. 1963, 85: 3533 -
10b
Gemal AL.Luche JL. J. Am. Chem. Soc. 1981, 103: 5454
References and Notes
General Procedure for the Reaction of 1.
A 30 mL two-necked round-bottomed flask, containing a magnetic stirring bar, Pd(TFA)2 (0.015 mmol), ligand (0.0225 mmol), p-benzoquinone (0.6 mmol) and MeOH (5 mL) was fitted with a rubber septum and a three-way stopcock connected to a balloon filled with CO. The apparatus was purged with CO by pumping-filling via the three-way stopcock. To the stirred solution the substrate 1 (0.3 mmol) was added dropwise (3 × 1 mL) via a syringe at 0 °C. After being stirred for a certain period at the appropriate temperature, the mixture was diluted with CH2Cl2 (30 mL), and washed with 2% Na2SO3 aq (30 mL). The organic layers were separated, the aqueous layer was extracted with CH2Cl2 (30 mL), and the combined organic layers were dried with MgSO4 and concentrated in vacuo. The crude product was purified by column chromatography on silica gel. The fraction eluted with hexane-EtOAc (100:1 to 50:1) afforded 2 and 3 (10:1). The products 2 were separated to give each diastereomer by preparative TLC. The ee of each diastereomer was determined by HPLC using Chiralcel OD column (hexane-EtOH = 150:1, FL = 1.0, for 3a-2) and Chiralcel OF column (hexane-EtOH = 150:1, FL = 0.5, for 3a-1). The relative stereochemistry of 3 was estimated as shown in Figure
[2]
, based on NOE experiments.
Compound 2a: slightly yellow needles; mp 56 °C. 1H NMR (CDCl3): δ = 2.80-2.84 (2 H, m), 2.89 (2 H, s), 2.95-2.99 (2 H, m), 3.44 (6 H, s), 5.35 (1 H, s), 7.18-7.31 (5 H, m). 13C NMR (CDCl3): δ = 26.5, 34.4, 41.1, 55.5, 98.7, 126.3, 128.4, 128.5, 141.0, 152.3, 161.4, 198.8, 200.3. MS-FAB: m/z = 275 [M+ + H]. IR (KBr): 2933, 1742, 1706 cm-1. Anal. Calcd (%) for C16H18O4: C, 70.06; H, 6.61. Found: C, 69.86; H, 6.57.
Compound 3a-1 (more polar diastereomer): colorless needles; mp 44 °C. 1H NMR (CDCl3): δ = 1.71 (3 H, s), 2.24-2.30 (1 H, m), 2.72 (1 H, s), 2.77-2.90 (2 H, m), 2.95-3.04 (1 H, m), 3.39 (3 H, s), 3.70 (3 H, s), 5.50 (1 H, s), 7.16-7.30 (5 H, m). 13C NMR (CDCl3): δ = 24.1, 30.2, 40.2, 50.3, 51.2, 74.5, 79.5, 81.5, 91.0, 124.2, 126.1, 128.5, 128.5, 141.0, 165.9, 168.0. HRMS (EI): m/z [M+] calcd for C18H20O5: 316.1311; found: 316.1304. IR (KBr): 3269, 2950, 2121, 1720, 1666 cm-1.
Compound 3a-2 (less polar diastereomer): colorless needles; mp 35 °C. 1H NMR (CDCl3): δ = 1.76 (3 H, s), 2.18-2.27 (1 H, m), 2.71 (1 H, s), 2.84-2.92 (1 H, m), 3.03-3.12 (2 H, m), 3.45 (3 H, s), 3.69 (3 H, s), 5.47 (1 H, s), 7.21-7.28 (5 H, m). 13C NMR (CDCl3): δ = 24.0, 30.5, 39.3, 49.6, 51.2, 74.6, 80.0, 80.3, 91.1, 124.5, 126.1, 128.5, 128.5, 141.2, 166.0, 167.4. HRMS (EI): m/z [M+] calcd for C18H20O5: 316.1311; found 316.1318. IR (KBr): 3246, 2949, 2113, 1708, 1658 cm-1.
Compound 2b: slightly yellow oil. 1H NMR (CDCl3): δ = 0.88 (3 H, t, J = 6.8 Hz), 1.22-1.56 (12 H, m), 2.65 (2 H, t, J = 7.8 Hz), 2.89 (2 H, s), 3.45 (6 H, s), 5.36 (1 H, s). 13C NMR (CDCl3): δ = 14.1, 22.7, 24.4, 28.4, 29.1, 29.2, 30.0, 31.8, 41.2, 55.5, 98.8, 151.7, 162.8, 198.9, 200.7. HRMS (EI): m/z [M+] calcd for C16H26O4: 282.1831; found: 282.1829. IR (neat): 2927, 1745, 1706 cm-1.
Compound 3b-1 (more polar diastereomer): colorless oil. 1H NMR (CDCl3): δ = 0.88 (3 H, t, J = 8.0 Hz), 1.22-1.35 (10 H, m), 1.39-1.52 (1 H, m), 1.57-1.71 (1 H, m), 1.68 (3 H, s), 1.99-2.06 (1 H, m), 2.41-2.49 (1 H, m), 2.66 (1 H, s), 3.36 (3 H, s), 3.70 (3 H, s), 5.47 (1 H, s). 13C NMR (CDCl3): δ = 14.1, 22.7, 23.8, 24.1, 29.2, 29.3, 29.4, 31.9, 38.4, 50.3, 51.1, 74.1, 79.9, 82.1, 90.6, 124.0, 165.9, 168.4. HRMS (EI): m/z [M+] calcd for C18H28O5: 324.1937; found: 324.1924. IR (KBr): 3281, 2927, 2120, 1723, 1657 cm-1.
Compound 3b-2 (less polar diastereomer): colorless oil. 1H NMR (CDCl3): δ = 0.88 (3 H, t, J = 7.0 Hz), 1.22-1.40 (10 H, m), 1.49-1.62 (1 H, m), 1.68-1.78 (1 H, m), 1.72 (3 H, s), 1.93-2.00 (1 H, m), 2.64-2.72 (1 H, m), 2.65 (1 H, s), 3.31 (3 H, s), 3.70 (3 H, s), 5.45 (1 H, s). 13C NMR (CDCl3): δ = 14.1, 22.7, 24.1, 24.1, 29.2, 29.4, 29.5, 31.9, 37.4, 49.5, 51.1, 74.2, 80.4, 80.8, 90.8, 124.3, 166.0, 167.9. HRMS (EI): m/z [M+] calcd for C18H28O5: 324.1937; found: 324.1965. IR (KBr): 3296, 2931, 2119, 1725, 1657 cm-1.
Compound 2c: colorless oil. 1H NMR (CDCl3): δ = 0.90 (3 H, t, J = 7.2 Hz), 1.31-1.37 (4 H, m), 1.47-1.54 (2 H, m), 2.65 (2 H, t, J = 7.8 Hz), 2.89 (2 H, s), 3.45 (6 H, s), 5.37 (1 H, s). 13C NMR (CDCl3): δ = 13.9, 22.3, 24.3, 28.1, 32.1, 41.2, 55.5, 98.7, 151.7, 162.8, 199.0, 200.7. HRMS (EI): m/z [M+] calcd for C13H20O4: 240.1362; found: 240.1352. IR (neat): 2932, 1745, 1706 cm-1.
Compound 3c-1 (more polar diastereomer): colorless oil. 1H NMR (CDCl3): δ = 0.89 (3 H, t, J = 7.2 Hz), 1.29-1.37 (4 H, m), 1.44-1.52 (1 H, m), 1.58-1.66 (1 H, m), 1.69 (3 H, s), 1.98-2.06 (1 H, m), 2.40-2.49 (1 H, m), 2.67 (1 H, s), 3.36 (3 H, s), 3.70 (3 H, s), 5.47 (1 H, s). 13C NMR (CDCl3): δ = 13.9, 22.4, 23.4, 24.0, 31.4, 38.3, 50.2, 51.1, 74.1, 79.8, 82.0, 90.6, 124.0, 165.9, 168.4. HRMS (EI): m/z [M+] calcd for C15H22O5: 282.1467; found: 282.1419. IR (KBr): 3248, 2952, 2122, 1710, 1656 cm-1. Anal. Calcd for C15H22O5: C, 63.83; H, 7.85. Found: C, 63.71; H, 7.89.
Compound 3c-2 (less polar diastereomer): colorless oil. 1H NMR (CDCl3): δ = 0.90 (3 H, t, J = 6.8 Hz), 1.31-1.37 (4 H, m), 1.51-1.61 (1 H, m), 1.68-1.79 (1 H, m), 1.73 (3 H, s), 1.92-2.00 (1 H, m), 2.65-2.72 (1 H, m), 2.65 (1 H, s), 3.31 (3 H, s), 3.70 (3 H, s), 5.45 (1 H, s). 13C NMR (CDCl3): δ = 13.9, 22.5, 23.7, 24.0, 31.5, 37.3, 49.5, 51.1, 74.2, 80.4, 80.8, 90.8, 124.3, 166.0, 167.9. HRMS (EI): m/z [M+] calcd for C15H22O5: 282.1467; found: 282.1466. IR (KBr): 3298, 2952, 2120, 1723, 1658 cm-1.
Compound 2d: colorless oil. 1H NMR (CDCl3): δ = 1.41 (3 H, s), 2.93 (2 H, s), 3.09 (2 H, s), 3.49 (6 H, s), 3.91-3.99 (4 H, m), 5.39 (1 H, s). 13C NMR (CDCl3): δ = 25.2, 32.7, 41.6, 56.1, 64.8, 100.1, 109.3, 153.1, 156.5, 198.5, 199.9. HRMS (EI): m/z [M+] calcd for C13H18O6: 270.1103; found: 270.1109. IR (neat): 3438, 2937, 1750, 1708 cm-1.
Compound 3d: inseparable mixture of diastereomers (ratio = 2.4:1); colorless oil. 1H NMR (CDCl3): δ (major diastereomer) = 1.56 (3 H, s), 1.73 (3 H, s), 2.44 (1 H, d, J = 15.2 Hz), 2.71 (1 H, s), 2.96 (1 H, d, J = 15.2 Hz), 3.38 (3 H, s), 3.70 (3 H, s), 3.87-4.08 (4 H, m), 5.46 (1 H, s). 1H NMR (CDCl3): δ = (minor diastereomer) = 1.61 (3 H, s), 1.76 (3 H, s), 2.18 (1 H, d, J = 14.8 Hz), 2.72 (1 H, s), 3.32 (1 H, d, J = 14.8 Hz), 3.35 (3 H, s), 3.70 (3 H, s), 3.87-4.08 (4 H, m), 5.43 (1 H, s). 13C NMR (CDCl3): δ (major diastereomer) = 23.7, 25.9, 44.9, 50.4, 51.1, 64.3, 64.5, 74.2, 79.1, 79.9, 90.1, 108.2, 124.5, 165.9, 168.8. 13C NMR (CDCl3): δ (minor diastereomer) = 24.1, 25.5, 43.9, 49.6, 51.1, 64.4, 64.5, 74.7, 77.9, 80.1, 90.3, 108.5, 125.2, 165.9, 168.5. HRMS (EI): m/z [M+] calcd for C15H20O7: 312.1209; found: 312.1191. IR (KBr): 3248, 2907, 2117, 1707, 1650 cm-1.
Compound 2e: colorless oil. 1H NMR (CDCl3): δ = 2.88 (2 H, s), 3.45 (6 H, s), 4.04 (2 H, s), 5.43 (1 H, s), 7.17-7.35 (5 H, m). 13C NMR (CDCl3): δ = 30.0, 41.3, 55.6, 98.7, 126.7, 128.5, 129.6, 136.6, 151.8, 159.6, 198.8, 200.3. HRMS (EI): m/z [M+] calcd for C16H16O4: 260.1049; found: 260.1054. IR (KBr): 2935, 1747, 1706 cm-1.
Compound 3e-1 (more polar diastereomer): colorless needles; mp 64 °C. 1H NMR (CDCl3): δ = 1.23 (3 H, s), 2.70 (1 H, s), 3.33 (3 H, s), 3.54 (1 H, d, J = 14.0 Hz), 3.78 (3 H, s), 3.81 (1 H, d, J = 14.0 Hz), 5.54 (1 H, s), 7.23-7.30 (5 H, m). 13C NMR (CDCl3): δ = 23.3, 43.9, 50.4, 51.3, 74.7, 80.2, 82.1, 91.3, 124.4, 127.4, 128.0, 131.3, 134.6, 166.1, 167.6 MS (EI): m/z = 302 [M+]. IR (KBr): 3262, 2115, 1716, 1657 cm-1. Anal. Calcd for C17H18O5: C, 67.54; H, 6.00. Found: C, 67.63; H, 6.05.
Compound 3e-2 (less polar diastereomer): colorless needles; mp 67 °C. 1H NMR (CDCl3): δ = 1.70 (3 H, s), 2.65 (1 H, s), 3.05 (3 H, s), 3.61 (1 H, d, J = 14.0 Hz), 3.77 (3 H, s), 3.87 (1 H, d, J = 14.0 Hz), 5.55 (1 H, s), 7.25-7.38 (5 H, m). 13C NMR (CDCl3): δ = 24.1, 42.7, 49.5, 51.3, 75.2, 80.3, 80.4, 91.5, 124.5, 127.2, 128.0, 131.2, 135.0, 166.2, 167.2. MS (EI): m/z = 302 [M+]. IR (KBr): 3262, 2117, 1716, 1651 cm-1. Anal. Calcd for C17H18O5: C, 67.54; H, 6.00. Found: C, 67.19; H, 6.02.